Relpax and Respiratory acidosis - a phase IV clinical study of FDA data

Summary:

Respiratory acidosis is reported as a side effect among people who take Relpax (eletriptan hydrobromide), especially for people who are female, 50-59 old, also take Paxil, and have Asthma.

The phase IV clinical study analyzes which people have Respiratory acidosis when taking Relpax. It is created by eHealthMe based on reports of 8,715 people who have side effects when taking Relpax from the FDA, and is updated regularly.

What is Relpax?

Relpax has active ingredients of eletriptan hydrobromide. It is often used in migraine. eHealthMe is studying from 9,259 Relpax users. Check the latest studies of Relpax.

What is Respiratory acidosis?

Respiratory acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease) is found to be associated with 2,241 drugs and 3,540 conditions by eHealthMe. Check the latest studies of Respiratory acidosis.

On Jul, 13, 2026

8,715 people reported to have side effects when taking Relpax.
Among them, 24 people (0.28%) have Respiratory acidosis.

Could Relpax cause Respiratory acidosis?

Among these 24 people:

What is the gender of people who have Respiratory acidosis when taking Relpax? *

female: 95.83 %
male: 4.17 %

What is the age of people who have Respiratory acidosis when taking Relpax? *

What are other drugs people take besides Relpax? *

What are other side effects people have besides Respiratory acidosis? *

Metabolic Acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body): 12 people, 50.00%
Enlarged Heart: 10 people, 41.67%
Ventricular Hypertrophy (enlargement of ventricles (lower chambers) in the heart): 9 people, 37.50%
Apnea (temporary absence or cessation of breathing): 9 people, 37.50%
Dyspnea (difficult or laboured breathing): 9 people, 37.50%
Drug Exposure During Pregnancy: 9 people, 37.50%
Cardiac Murmur (an heart sound in valve abnormality): 9 people, 37.50%
Cardiac Arrest: 9 people, 37.50%
Lung Disorder (lung disease): 9 people, 37.50%
Bundle Branch Block Right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle): 9 people, 37.50%

What are the existing conditions these people have? *

Quit Smoking: 4 people, 16.67%
Asthma: 4 people, 16.67%
Abdominal Pain: 2 people, 8.33%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 8.33%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 8.33%
Circadian Rhythm Sleep Disorder (family of sleep disorders affecting, among other things, the timing of sleep): 2 people, 8.33%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 8.33%
Sleep Disorder: 2 people, 8.33%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 4.17%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Relpax and have Respiratory acidosis?

- Check whether Respiratory acidosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Relpax:

Relpax (9,259 reports)

Browse all side effects of Relpax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Respiratory acidosis:

Respiratory acidosis (2,241 drugs)

Browse all the conditions that are associated with Respiratory acidosis:

Respiratory acidosis (3,540 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on eletriptan hydrobromide (the active ingredients of Relpax) and Relpax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.